
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue
Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually